ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 462

The Endogenous Plasma Small RNAome of Rheumatoid Arthritis

Michelle Ormseth1, Joseph Solus 2, Quanhu Sheng 2, Fei Ye 2, Haocan Song 2, Qiong Wu 2, Yan Guo 3, Annette Oeser 2, Ryan Allen 2, Kasey Vickers 2 and C. Michael Stein 2, 1Vanderbilt University Medical Center and Veterans Administration: TN Valley Healthcare System, Nashville, 2Vanderbilt University Medical Center, Nashville, 3University of New Mexico, Albuquerque

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biomarkers and Disease Activity, MicroRNA, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Small RNA (sRNA) sequencing has revealed new classes of sRNAs beyond microRNAs. These sRNAs can regulate genes and are also useful biomarkers of disease. The aim of this study was to determine if the endogenous plasma sRNA landscape of patients with RA is altered compared to control subjects and determine their association with disease-related parameters in RA.

Methods: sRNA sequencing was performed on plasma from 165 RA and 90 control subjects who were frequency-matched for age, race and sex. TIGER pipeline was used to quantify endogenous sRNAs including microRNAs and sRNAs derived from small nuclear RNAs (snDRs), small nucleolar RNAs (snoDRs), YRNAs (yDRs), transfer RNAs (tDRs), long non-coding RNAs (lncDRs), miscellaneous sRNAs (miscRNAs), and sRNAs aligning to the human genome but not annotated sRNAs categories (such as sRNAs aligning to messenger RNAs or precursors such as pre-rRNAs). Sequencing reads were normalized to million total reads. The reads in each sRNA category were compared between RA and control subjects and correlated with disease activity measures and general laboratory measures with Spearman correlation. The correlations were presented using heatmap with hierarchical clustering.

Results: The largest proportion of endogenous plasma sRNAs was yDRs, followed by microRNAs. Patients with RA had more microRNAs (1.42-fold, P=0.01), more tDRs (1.14-fold, P=0.04), and fewer yDRs (-1.41-fold, P=0.009) compared to control subjects (Figure 1), but other sRNAs as classes were not significantly different in RA. Disease duration was inversely associated with yDRs (Figure 2). Disease-related parameters such as DAS28 score, swollen joint count, and inflammatory markers were significantly positively associated with genome reads not classified as a sRNA category, tDRs and miscRNAs (Figure 2).

Conclusion: Endogenous plasma sRNAs are altered in patients with RA compared to control subjects. While individual miRNAs have been well studied and many are excellent biomarkers in RA, non-miRNA sRNA and unclassified sRNAs were significantly associated with disease related parameters as classes and may represent novel biomarkers for RA.


Fig 1 redo

Figure 1. Proportions of endogenous plasma sRNAs in RA and control subjects. Proportions were calculated using the geometric mean of the sRNAs due to skewness.


fig 2

Figure 2. Heatmap with hierarchical clustering demonstrating the relationship between sequencing reads of plasma sRNAs based on category.


Disclosure: M. Ormseth, None; J. Solus, None; Q. Sheng, None; F. Ye, None; H. Song, None; Q. Wu, None; Y. Guo, None; A. Oeser, None; R. Allen, None; K. Vickers, None; C. Stein, None.

To cite this abstract in AMA style:

Ormseth M, Solus J, Sheng Q, Ye F, Song H, Wu Q, Guo Y, Oeser A, Allen R, Vickers K, Stein C. The Endogenous Plasma Small RNAome of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-endogenous-plasma-small-rnaome-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-endogenous-plasma-small-rnaome-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology